Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. 23295781 Parikh H, Jia J, Zhang X, Chung CC, Jacobs KB, Yeager M, Boland J, Hutchinson A, Burdett L, Hoskins J, Risch HA, Stolzenberg-Solomon RZ, Chanock SJ, Wolpin BM, Petersen GM, Fuchs CS, Hartge P, Amundadottir L Pancreas 2013 PLCO
Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. 22893105 Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H Cancer 2013 PLCO
Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. 23065684 Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD Int. J. Cancer 2013 PLCO
An aggregated analysis of hormonal factors and endometrial cancer risk by parity. 23280123 Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV Cancer 2013 PLCO
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. 23112111 Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutr… Cancer Causes Control 2013 PLCO
Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. 23171878 Chaturvedi AK, Moore SC, Hildesheim A Am. J. Epidemiol. 2013 PLCO
Individual variations in serum melatonin levels through time: implications for epidemiologic studies. 24376664 Nogueira LM, Sampson JN, Chu LW, Yu K, Andriole G, Church T, Stanczyk FZ, Koshiol J, Hsing AW PLoS ONE 2013 PLCO
Telomere length and risk of glioma. 24231251 Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA Cancer Epidemiol 2013 PLCO
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. 24115361 Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK J. Natl. Cancer Inst. 2013 PLCO
Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. 23907431 Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J Br. J. Cancer 2013 PLCO
Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. 24089460 Mir MC, Stephenson AJ, Grubb RL, Black A, Kibel AS, Izmirlian G Cancer Epidemiol. Biomarkers Prev. 2013 PLCO
Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial. 23993734 Hocking WG, Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC Lung Cancer 2013 PLCO
Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. 23624999 Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL, Hofmann JN, Chow WH, Purdue MP Am. J. Epidemiol. 2013 PLCO
Association of obesity with cardiovascular disease mortality in the PLCO trial. 23632233 Jiang J, Ahn J, Huang WY, Hayes RB Prev Med 2013 PLCO
Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. 23559420 Barocas DA, Grubb R, Black A, Penson DF, Fowke JH, Andriole G, Crawford ED Cancer 2013 PLCO
Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. 23248253 Drescher CW, Shah C, Thorpe J, O'Briant K, Anderson GL, Berg CD, Urban N, McIntosh MW J. Clin. Oncol. 2013 PLCO
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. 23935463 Pfeiffer RM, Park Y, Kreimer AR, Lacey JV, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P PLoS Med. 2013 PLCO
Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. 23715565 Kitahara CM, Berndt SI, de González AB, Coleman HG, Schoen RE, Hayes RB, Huang WY J. Clin. Oncol. 2013 PLCO
Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. 23263487 Jia WH, Zhang B, Matsuo K, Shin A, Xiang YB, Jee SH, Kim DH, Ren Z, Cai Q, Long J, Shi J, Wen W, Yang G, Delahanty RJ, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Colon Cancer Family Registry (CCFR), Ji BT, Pan ZZ, Matsuda F, … Nat. Genet. 2013 PLCO
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. 23266556 Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Chen LS, Coetzee GA, Coetzee SG, Conti DV, Curtis KR, Du… Gastroenterology 2013 PLCO